You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 132 No. 1, January 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Academic Surgeons' Knowledge of Food and Drug Administration Regulations for Clinical Trials

Randi L. Rutan, RN; Edwin A. Deitch, MD; J. Paul Waymack, MD, ScD

Arch Surg. 1997;132(1):94-98.


Abstract

Objectives
To identify knowledge levels of academic surgeons about Food and Drug Administration (FDA) and Institutional Review Board (IRB) regulations for clinical research and to determine whether being a member in an IRB, conducting or participating in clinical trials, or being a member in surgical societies affected knowledge levels.

Design
Survey of surgical department faculty members in 20 universities.

Results
Sixty-five responses were received from 14 sites. Overall mean (±SEM) correct score was 6.7±0.2 of a possible 20 points. The best predictor of overall score was being a primary investigator of a clinical trial (P<.001), followed by being or having been a member of an IRB (P≤.02). The total mean score of members of the Surgical Infection Society (8.2±0.5) was significantly higher (P<.001) than that of nonmembers (6.1±0.2), a phenomenon not observed with other surgical societies. In certain hypothetical clinical scenarios, all respondents were mistakenly willing to conduct clinical trials without obtaining appropriate approval from the FDA. Four (22%) of 18 IRB member respondents and 16 (25%) of the 65 respondents were willing to conduct human research without appropriate approval from patients, the IRB, or both.

Conclusions
Knowledge deficits exist in the academic surgical community about the role and requirements of the FDA and local IRBs for conducting clinical research. Further study is required to determine the reasons for this deficit and to identify appropriate interventions.

Arch Surg. 1997;132:94-98



Author Affiliations

From the Department of Surgery, University of Medicine and Dentistry of New Jersey—New Jersey Medical School, Newark. Dr Waymack is now in private practice in Frederick, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

On Knowledge of Regulations for Clinical Trials
Boba
Arch Surg 1997;132:682-682.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.